USPTO serial 87115100
GREY WOLF ANIMAL HEALTH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- STRINGER, DANIEL
- Law office
- TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with GREY WOLF ANIMAL HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
George T. Wu
GEORGE T. WU MCANDREWS, HELD & MALLOY, LTD.500 W. MADISON ST.34TH FLOORCHICAGO, IL 60661Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Veterinary pharmaceutical preparations for animals and poultry to give newborn animals and birds a healthy start; veterinary pharmaceutical preparations for periodontal diseases; veterinary pharmaceutical preparations for respiratory and reproductive diseases in dogs, cats, horses, cattle, goats and sheep; veterinary pharmaceutical preparations for the treatment of arthritis, muscle soreness and sprains; veterinary pharmaceutical preparations for the treatment of bacterial infections in dogs, cats, horses, cattle, goats and sheep; veterinary pharmaceutical preparations for the treatment of infectious diseases in poultry; veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections, topical infections; veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, swine dysentery, bacterial enteritis, Bluecomb, pneumonia; veterinary pharmaceutical preparations for the treatment of nutritional muscular dystrophy; veterinary pharmaceutical preparations for the treatment of parasites; veterinary pharmaceutical preparations for the treatment of vitamin deficiencies; veterinary pharmaceutical preparations for udder care; veterinary pharmaceuticals for parturition induction in swine; veterinary pharmaceutical preparations, namely, antiparasitics, anti-inflammatories, antibiotics, anti-infectives, reproductive hormone preparations, and dental preparations for preventing the build-up of plaque, bacteria and calculus; veterinary pharmaceutical preparations for restoring and improving the intestinal function in small and large animals; veterinary pharmaceutical preparations for the treatment of cancer and dermatological illnesses in dogs, cats, horses, cattle, goats and sheep; veterinary pharmaceutical preparations, namely, nutritional additives to foodstuffs for animals, injectable concentrates of vitamins; veterinary pharmaceutical preparations for the treatment of infectious respiratory and enteric diseases in animals; veterinary pharmaceutical preparations, namely treatments for anxiety and central nervous system disorders in companion animals; veterinary pharmaceutical preparations containing glycotechnology for the management of dermatitis, keratoseborrheic disorders, and otitis externa in dogs, cats, horses, cattle, goats and sheep; veterinary pharmaceutical preparations for the treatment of feline hyperthyroidism; veterinary pharmaceutical preparations for use in the treatment or prevention of fleas in companion animals; veterinary pharmaceutical preparations, namely, concomitant medication in the treatment of respiratory disease in young cattles, prevention of post-weaning respiratory disease, growth promotors, vitaminised antibiotic complexes, vitaminised mineral complexes, lactic bacteria for early, massive and prolonged seeding of the gut flora of newborn calves, polyvalent antihelmintics for cattle and sheep, anti-microbial feed premixes; veterinary pharmaceutical preparations, namely, for the prevention of stress; veterinary pharmaceutical preparations, namely, soluble powder for the prevention and treatment of poultry diseases; nutraceuticals, namely, dietary supplements and food supplements fortified with bacteria, enzymes, vitamins, minerals, protein, fibres and grains, for medical and veterinary purposes; nutritional additives for use as a nutritional supplement for medical and veterinary purposes, namely, nutritional additives containing bacteria, enzymes, vitamins, minerals, potato protein, fermented potato protein, and roughage, namely, fibres and grains; dietetic substances for medical and veterinary purposes for pigs, cattle and poultry, namely, dietetic supplements containing one or more of vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K, niacin, potato protein and fermented potato protein for improving the yield of milk in ruminant animals, stimulating the rumen fermentation in ruminant animals, reducing viral infection pressure, reducing bacterial infection pressure, lowering birth mortality, improving low animal weight at birth, improving feed conversion, reducing the number of animal runts, increasing homogeneity in animal groups, improving animal fertility and increasing yields in animals; medicinal additives for foodstuffs for animals in the nature of nutritional supplements containing one or more of pomace, foodmix based on grain and pomace, carbohydrates, crude fibres, amino acids, minerals, bacteria, enzymes, vitamins, minerals, potato protein, fermented potato protein, and roughage, trace elements and vitamins; nutritional additives for animals, namely, non-medicinal additives for animal feed for use as nutritional supplements; disinfectants; antibacterial and antiseptic preparations for veterinary use, namely, hand washes, hand foams, gels and sprays; cloths, wipes, pads, tissues and sponges impregnated with antibacterial and antiseptic preparations | ACTIVE | — |
| 010 | Hygienical products for veterinary purposes, namely, veterinary needles, hypodermic syringes for veterinary use | ACTIVE | — |
| 044 | Operating a website providing information in the field of veterinary products, namely, veterinary pharmaceuticals, nutraceuticals for veterinary purposes, and antibacterial and antiseptic preparations for veterinary use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Grey Wolf Animal Health Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named GREY WOLF ANIMAL HEALTH
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 8, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 8, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 29, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2018 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 11, 2018 | ALIE | ASSIGNED TO LIE | — |
| Nov 27, 2017 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 24, 2017 | ALIE | ASSIGNED TO LIE | — |
| May 14, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 14, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 14, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 12, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 11, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 11, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 11, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 11, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 11, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 3, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 29, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 28, 2016 | NWAP | NEW APPLICATION ENTERED | — |